Back
Destination XL Group Vs. Corcept Therapeutics Industry Stock Comparison
Sell
36
DXLG
Destination XL Group
Last Price:
2.78
Seasonality Move:
-4.83%
Buy
68
CORT
Corcept Therapeutics
Last Price:
40.92
Seasonality Move:
-0.77%
Sell
36
Destination XL Group (DXLG)
is a Sell
Is Destination XL Group a Buy, Sell or Hold?
- The current Destination XL Group [DXLG] share price is $2.77. The Score for DXLG is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
- DXLG is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
68
Corcept Therapeutics (CORT)
is a Buy
Is Corcept Therapeutics a Buy, Sell or Hold?
- The current Corcept Therapeutics [CORT] share price is $42.27. The Score for CORT is 68, which is 36% above its historic median score of 50, and infers lower risk than normal.
- CORT is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
DXLG Stock Price Chart
What is Destination XL Group's stock price today?
-
The Destination XL Group share price today is $2.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and DXLG is experiencing selling pressure, which indicates risk of future bearish movement.
CORT Stock Price Chart
What is Corcept Therapeutics's stock price today?
-
The Corcept Therapeutics share price today is $42.27
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CORT is experiencing slight buying pressure.
DXLG Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.09 | Sell |
Relative Strength Index (14 RSI): | 44.85 | Sell |
Chaikin Money Flow: | -189204 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.66 - 2.92) | Sell |
Bollinger Bands (100): | (2.95 - 3.63) | Sell |
CORT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.36 | Buy |
Relative Strength Index (14 RSI): | 82.3 | Buy |
Chaikin Money Flow: | 670376 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.47 - 37.45) | Buy |
Bollinger Bands (100): | (28.16 - 35.86) | Buy |
DXLG Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.7 | Buy |
20-day SMA: | 2.75 | Buy |
50-day SMA: | 3.11 | Sell |
200-day SMA: | 3.59 | Sell |
8-day EMA: | 2.74 | Buy |
20-day EMA: | 2.79 | Sell |
50-day EMA: | 3.01 | Sell |
200-day EMA: | 3.56 | Sell |
CORT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 37.44 | Buy |
20-day SMA: | 35.75 | Buy |
50-day SMA: | 34.88 | Buy |
200-day SMA: | 28.43 | Buy |
8-day EMA: | 38.24 | Buy |
20-day EMA: | 36.43 | Buy |
50-day EMA: | 34.68 | Buy |
200-day EMA: | 30.05 | Buy |
Destination XL Group Earnings Growth & DXLG Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.05 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.31 per share, and a decrease next year of $0.28 per share.
Corcept Therapeutics Earnings Growth & CORT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.15 per share, an increase this year of $0.22 per share, and an increase next year of $0.59 per share.
Destination XL Group Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Corcept Therapeutics Technical Analysis
Sep 5 | Sep 6 | Sep 9 | Sep 10 | Sep 11 | Sep 12 | Sep 13 | Sep 16 | Sep 17 | Sep 18 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
05 | 06 | 09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |